Does Semaglutide Cause Dehydration?
Semaglutide, the active ingredient in drugs like Ozempic and Wegovy for diabetes and weight loss, lists dehydration as a possible side effect. It slows gastric emptying and affects appetite, which can lead to reduced fluid intake. Common gastrointestinal issues—nausea (up to 44% of users), vomiting (24%), and diarrhea (30%)—cause fluid loss through these routes, increasing dehydration risk.[1][2]
How Does It Happen?
Dehydration stems mainly from GI effects: persistent vomiting or diarrhea flushes electrolytes and water. In trials, 1-5% of patients reported dehydration directly, often linked to these symptoms. Low food and water intake during nausea exacerbates it. Elderly patients or those with kidney issues face higher risks due to slower recovery.[1][3]
What Symptoms Should You Watch For?
Signs include dry mouth, dizziness, reduced urine output, fatigue, headache, or confusion. Severe cases can lead to acute kidney injury (reported in post-marketing data) or hospitalization. Monitor closely in the first weeks of treatment when side effects peak.[2][4]
Who Is Most at Risk?
- People with intense GI reactions (e.g., >10% body weight loss quickly).
- Those on diuretics, with heart failure, or kidney disease.
- Older adults or anyone skipping meals/drinks due to nausea.
Diabetes patients on semaglutide had higher dehydration rates in studies versus placebo.[1][3]
Prevention and Management Tips
Drink 8-10 glasses of water daily, even if nauseous—sip slowly. Use oral rehydration solutions with electrolytes during diarrhea. Start low-dose to minimize GI upset. Doctors often recommend anti-nausea meds like ondansetron. If dehydrated, stop semaglutide and seek care; IV fluids fix most cases.[2][5]
Compared to Other GLP-1 Drugs
Semaglutide's dehydration risk mirrors tirzepatide (Mounjaro) and liraglutide (Saxenda), all sharing GI profiles. Head-to-head data shows similar rates, but semaglutide's longer action may prolong symptoms.[3]
When to See a Doctor
Contact a provider for persistent vomiting (>24 hours), dark urine, rapid heartbeat, or fainting. FDA labels warn of kidney problems from dehydration.[1][4]
Sources:
[1] Ozempic Prescribing Information - https://www.novo-pi.com/ozempic.pdf
[2] Wegovy Prescribing Information - https://www.novo-pi.com/wegovy.pdf
[3] NEJM Trial on Semaglutide (STEP 1) - https://www.nejm.org/doi/full/10.1056/NEJMoa2032183
[4] FDA Adverse Event Reporting - https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/semaglutide-marketed-ozempic-and-wegovy-information
[5] Mayo Clinic on GLP-1 Side Effects - https://www.mayoclinic.org/drugs-supplements/semaglutide-injection/side-effects/drg-20495275